My Firm and Reports

My company is ImpediMed, they specialize in accuratly mesuring the amount of fluids in the human body to determine the chances of and severity of chronic diseases with their SOZO Digital Health Platform. Their current CEO is David Anderson, although last year it was Richard Carreon.

Their 2022 revenue was around 10.6 million which was a 24% increase from 2021, their stock price is at around 0.14 AUD, all of these which are still rising. To me this seems like a very stable and profitable company which i am glad to receive.

Backround information: https://www.impedimed.com/#:~:text=ImpediMed%27s%20bioimpedance%20spectroscopy%20(BIS)%20systems,and%20interventions%20for%20chronic%20diseases.

Annual Reports: https://www.impedimed.com/about/investors/financial-reports/